Sodium Zirconium Cyclosilicate(ZS)

Phase 2

Phase 2

Development Phase

0

Upcoming Catalysts

0

Historical Events

1

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Drug Information

Target Indication

Hyperkalemia

Clinical Trial

Last updated: 1/9/2026

Regulatory Approvals

EMA

3/22/2018

Lokelma

Lokelma is indicated for the treatment of hyperkalaemia in adult patients.

Developer

AZN.L

AstraZeneca PLC

Related Pipeline

Diabetes

Asthma

Non-small Cell Lung Cancer

Type 2 Diabetes Mellitus

Chronic Obstructive Pulmonary Disease (COPD)